In the present work, a series of novel isatin-indole conjugates (7a-j and 9a-e) was designed and synthesised as potential antiproliferative agents towards colon cancer cells with promising inhibitory activity against the anti-apoptotic Bcl2 and BclxL proteins. The gene discussed is BCL2L1; the disease is malignant colon neoplasm.